Compare STRS & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STRS | BHST |
|---|---|---|
| Founded | 1992 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Homebuilding | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.1M | 137.1M |
| IPO Year | N/A | N/A |
| Metric | STRS | BHST |
|---|---|---|
| Price | $24.59 | $5.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 14.2K | ★ 59.8K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $31,912,000.00 | ★ $32,720,000.00 |
| Revenue This Year | N/A | $116.40 |
| Revenue Next Year | N/A | $55.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 45.88 |
| 52 Week Low | $15.10 | $4.72 |
| 52 Week High | $26.30 | $12.80 |
| Indicator | STRS | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 64.56 | 39.16 |
| Support Level | $23.95 | $5.32 |
| Resistance Level | $26.30 | $5.69 |
| Average True Range (ATR) | 0.93 | 0.46 |
| MACD | 0.04 | 0.10 |
| Stochastic Oscillator | 72.97 | 22.29 |
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.